Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama discusses how hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation and received tocilizumab showed a reduction in the likelihood of progression to the composite outcome of mechanical ventilation or death, but it did not improve survival.

Image courtesy of Carlos Salama

Image courtesy of the interviewee


Report Infringement

Sign-up

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Talking to Teens about Pain

Next Article

Political behavior in organizations

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×